Overview

• FDA clearance applies to dogs and puppies aged six months and older.
• A single injection delivers continuous protection against fleas and multiple tick species for eight to 12 months.
• Licensed veterinarians will determine individualized dosing intervals based on regional tick threats.
• The active ingredient fluralaner carries a rare risk of neurological reactions such as tremors, ataxia or seizures.
• U.S. veterinary clinics will roll out the treatment in August to address compliance challenges with shorter-acting products.